IMM 1.64% 30.0¢ immutep limited

Overnight Market report, page-1578

  1. 100 Posts.
    lightbulb Created with Sketch. 24
    I am sure the patients and their families care about the road they are on. Eftilagimod has shown it has the ability to extend lives. Immutep has trouble propping up the sp without approval. Unless we get data thats remarkable then im sure sp will wait until we go to mark.et
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.